The Immune Cell Transfer Therapy works by isolating and activating a patient's own immune cells, such as T cells, outside the body and then re-infusing them back to the patient, where they can recognize and attack cancer cells. This personalized approach has shown promising results in clinical trials, with some patients experiencing complete remission and long-term survival, This therapy represents a significant advancement in the field of cancer treatment, offering a potential alternative to traditional treatments like chemotherapy and radiation therapy. The team at Beijing BIOOCUS Biotech Ltd. is dedicated to furthering research and development in this area, with a commitment to improving patient outcomes and quality of life, Contact us to learn more about Immune Cell Transfer Therapy and how it may benefit patients with cancer
Please feel free to give your inquiry in the form below We will reply you in 24 hours